Goldman Sachs Group Inc Teva Pharmaceutical Industries LTD Call Options Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $44.4 Million - $60.5 Million	3,475,200 New	3,475,200 $56.5 Million
Q4 2023 Feb 13, 2024	SELL	$8.12 - $10.63 $6.17 Million - $8.08 Million	-759,900 Reduced 24.79%	2,305,500 $24.1 Million
Q3 2023 May 14, 2024	BUY	$7.48 - $10.7 $5.68 Million - $8.13 Million	759,900 Added 32.96%	3,065,400 $31.3 Million
Q2 2023 May 14, 2024	BUY	$7.2 - $9.47 $259,200 - $340,920	36,000 Added 1.19%	3,065,400 $23.1 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $259,200 - $340,920	36,000 Added 1.19%	3,065,400 $23.1 Million
Q1 2023 May 14, 2024	SELL	$8.36 - $11.37 $6.52 Million - $8.87 Million	-780,100 Reduced 20.48%	3,029,400 $26.8 Million
Q1 2023 May 11, 2023	SELL	$8.36 - $11.37 $6.52 Million - $8.87 Million	-780,100 Reduced 20.48%	3,029,400 $26.8 Million
Q3 2022 May 14, 2024	SELL	$6.86 - $11.95 $4.31 Million - $7.51 Million	-628,700 Reduced 14.17%	3,809,500 $30.7 Million
Q3 2022 Nov 10, 2022	SELL	$6.86 - $11.95 $4.31 Million - $7.51 Million	-628,700 Reduced 14.17%	3,809,500 $30.7 Million
Q2 2022 May 14, 2024	BUY	$7.38 - $10.4 $15.7 Million - $22.2 Million	2,132,700 Added 92.5%	4,438,200 $33.4 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $3.53 Million - $4.98 Million	478,900 Added 12.1%	4,438,200 $33.4 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $367,966 - $471,378	-50,200 Reduced 1.25%	3,959,300 $37.2 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $30.6 Million - $39.5 Million	3,871,700 Added 2809.65%	4,009,500 $32.1 Million
Q3 2021 Nov 10, 2021	BUY	$8.38 - $10.18 $1.15 Million - $1.4 Million	137,800 New	137,800 $1.34 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$752 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$636 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$566 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$505 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$463 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account